Evidence map›Paper›PMID 41318885›Full record

ArticleAnnals of surgical oncology2026

Sex-Associated Aspects of Referral, Resectability, and Survival in Patients with Colorectal Liver Metastases (CRLM): A Population-Based Single-Center Study of 1207 MDT-Referred Patients.

Martina Nebbia, Christina Villard, Stefan Gilg, Ernesto Sparrelid, Marco Gerling, Jennie Engstrand

Abstract read
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martina NebbiaDivision of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Christina VillardDivision of Transplantation Surgery, Department of Clinical Science, Innovation and Technology, Karolinska Institutet, Stockholm, Sweden.
Stefan GilgDivision of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Ernesto SparrelidDivision of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Marco GerlingDivision of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Jennie EngstrandDivision of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. jennie.engstrand@ki.se.

Funding

The Swedish Cancer Society 22 2175The Swedish Research Council 2018-02023The Swedish Research Council 2024-03026
6 · The paper itself

Abstract

backgroundSex-related differences in colorectal cancer biology and care are increasingly recognized, but their impact on colorectal liver metastases (CRLM) management remains unclear. Previous Swedish registry studies suggested that women undergo CRLM surgery less often than men. This study aimed to further explore sex-associated patterns of referral rates, resectability assessment, and survival in a contemporary, multidisciplinary team (MDT)-reviewed cohort of patients with CRLM.

methodsThe study enrolled all patients with CRLM referred to the Stockholm regional liver MDT between 2013 and 2021. Tumor characteristics, treatment allocation, and survival were compared by sex. Multivariable logistic and Cox regression models were used to assess predictors of resection and survival.

resultsOf 1207 MDT-referred patients, 467 (39%) were women and 740 (61%) were men. The women were younger at diagnosis and had a higher prevalence of KRAS mutations, whereas metastatic burden and extrahepatic spread were comparable between the sexes. Curative interventions were performed for 59% of the women and 62% of the men (p = 0.219), with no differences in surgical extent, complications, or postoperative outcomes. Among palliatively treated patients, survival was similar, and multivariable Cox models identified no independent association between sex and survival in any subgroup.

conclusionsIn this large, population-based MDT cohort, sex was not associated with differences in resectability, treatment, or survival. The study underscored the importance of centralized and mandatory MDT referral pathways to ensure equitable access to curative-intent treatment and standardized management for all patients with metastatic colorectal cancer.

Indexed as

Colorectal NeoplasmsHepatectomyLiver NeoplasmsPatient Care TeamReferral and ConsultationAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisSex FactorsSurvival RateAblationColorectal liver metastases (CRLM)KRASLiver resectionMultidisciplinary team (MDT)Sex differences

Identifiers

PMID41318885
PMCPMC12901161

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.